publication . Other literature type . Article . 2013

Antiviral cell therapy: is this the future?

Juan C. Gea-Banacloche;
Open Access English
  • Published: 27 Jun 2013
  • Publisher: American Society of Hematology
Abstract
In this issue of Blood , Leen and colleagues report the first multicenter trial of third-party viral-specific T cells (VSTs) for the treatment of 50 patients with refractory viral infections (cytomegalovirus, adenovirus, and Epstein-Barr virus) after stem cell transplantation.[1][1] How is this
Subjects
Medical Subject Headings: viruses
free text keywords: Inside Blood, Immunology, Cell Biology, Biochemistry, Hematology, Multicenter trial, Hematopoietic stem cell transplantation, medicine.medical_treatment, medicine, Virus, Epstein–Barr virus infection, medicine.disease, Refractory, Adenoviridae Infections, Stem cell, Cell therapy, business.industry, business, Virology
Related Organizations
Download fromView all 2 versions
Europe PubMed Central
Other literature type . 2013
Blood
Article
Provider: UnpayWall
Blood
Article . 2013
Provider: Crossref
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Other literature type . Article . 2013

Antiviral cell therapy: is this the future?

Juan C. Gea-Banacloche;